首页> 美国卫生研究院文献>The Oncologist >Does a Diagnosis of Myelogenous Leukemia Require 20 Marrow Myeloblasts and Does 5 Marrow Myeloblasts Represent a Remission? The History and Ambiguity of Arbitrary Diagnostic Boundaries in the Understanding of Myelodysplasia
【2h】

Does a Diagnosis of Myelogenous Leukemia Require 20 Marrow Myeloblasts and Does 5 Marrow Myeloblasts Represent a Remission? The History and Ambiguity of Arbitrary Diagnostic Boundaries in the Understanding of Myelodysplasia

机译:诊断骨髓性白血病需要20%的骨髓成纤维细胞5%的骨髓成纤维细胞代表缓解吗?了解骨髓增生异常的任意诊断边界的历史和模糊性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

This commentary discusses the current use of arbitrary boundaries to distinguish the continuum of incipient (clonal cytopenias), oligoblastic (subacute), and polyblastic (acute) myelogenous leukemia. The historical path that led to the application of these boundaries is discussed, and simplification of the current diagnostic classification is proposed.
机译:这篇评论讨论了当前使用任意界限来区分初始(克隆性血细胞减少症),成寡细胞(亚急性)和多细胞性(急性)骨髓性白血病的连续性。讨论了导致这些边界应用的历史路径,并提出了简化当前诊断分类的方法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号